MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 27 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,000 | -50.0% | 2,024 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 2,024 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -50.0% | 2,024 | +93.7% | 0.00% | – |
| Q1 2016 | $6,000 | -14.3% | 1,045 | +19.4% | 0.00% | – |
| Q4 2015 | $7,000 | +16.7% | 875 | +12.6% | 0.00% | – |
| Q3 2015 | $6,000 | -33.3% | 777 | 0.0% | 0.00% | – |
| Q2 2015 | $9,000 | 0.0% | 777 | -21.2% | 0.00% | – |
| Q1 2015 | $9,000 | 0.0% | 986 | +9.9% | 0.00% | – |
| Q4 2014 | $9,000 | +50.0% | 897 | 0.0% | 0.00% | – |
| Q3 2014 | $6,000 | – | 897 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 5,016,164 | $10,835,000 | 2.15% |
| Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,836,000 | 1.91% |
| Asymmetry Capital Management, L.P. | 354,853 | $766,000 | 1.37% |
| Lion Point Capital, LP | 6,374,740 | $13,769,000 | 1.28% |
| Granite Point Capital Management, L.P. | 2,700,000 | $5,832,000 | 0.91% |
| VHCP Management II, LLC | 1,486,676 | $3,211,000 | 0.85% |
| Boxer Capital, LLC | 4,800,000 | $10,368,000 | 0.59% |
| Avoro Capital Advisors LLC | 6,200,000 | $13,392,000 | 0.39% |
| 683 Capital Management, LLC | 925,382 | $1,999,000 | 0.23% |
| Islet Management, LP | 875,000 | $1,890,000 | 0.18% |